Stroke · 2026
COL4A1 and COL4A2 Gene Duplication or Triplication as a Genetic Cause of Cerebral Small Vessel Disease in Adults.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Hervé Dominique, Lesnik Oberstein Saskia A J, Pipiras Eva, Kittner Steven J, Renard Dimitri, Morel Hélène, Bergametti Françoise, Corpechot Michaelle, Nibbeling Esther A R, Boulday Gwenola, Guey Stéphanie, Aloui Chaker, Chabriat Hugues, Tournier-Lasserve Elisabeth, Coste Thibault
Аннотация
BACKGROUND: Cerebral small vessel disease (CSVD) is a major cause of stroke and vascular cognitive impairment, yet its mechanisms remain incompletely understood. While heterozygous point mutations in COL4A1 and COL4A2 are established monogenic cause of CSVD, the contribution of copy number gains involving these 2 genes has only recently been recognized. We aimed to define the clinical and radiological spectrum of COL4A1/2 duplications and triplications in adults.
METHODS: We report 7 adult probands carrying duplications or triplications of COL4A1 and COL4A2, in whom no pathogenic variants were identified in other known CSVD genes. Targeted high-throughput sequencing, quantitative multiplex polymerase chain reaction of short fluorescent fragments, and SNP arrays were used to confirm and characterize genomic rearrangements spanning the 13q33q34 region.
RESULTS: Genomic rearrangements ranged from 328 kb to 11.8 Mb, involving complete or partial duplication/triplication of COL4A1/2. Patients presented heterogeneous cerebrovascular manifestations, including ischemic and hemorrhagic events, motor impairment, and cognitive decline. Brain magnetic resonance imaging consistently showed extensive white matter hyperintensities, lacunes (particularly in the pons), microbleeds, and, in some cases, saccular aneurysms or arterial dolichoectasia. Only 2 probands had a positive family history of CSVD.
CONCLUSIONS: This large series confirms the pathogenicity of COL4A1/2 duplications and triplications in adult-onset CSVD. Phenotypic variability likely reflects differences in duplication/triplication size, gene content, and modifying factors. Our findings highlight a distinct cerebral-only phenotype linked to gene dosage-related overexpression and underscore the importance of screening for copy number variations in patients with otherwise unexplained cerebral microangiopathy, even in the absence of a family history.
METHODS: We report 7 adult probands carrying duplications or triplications of COL4A1 and COL4A2, in whom no pathogenic variants were identified in other known CSVD genes. Targeted high-throughput sequencing, quantitative multiplex polymerase chain reaction of short fluorescent fragments, and SNP arrays were used to confirm and characterize genomic rearrangements spanning the 13q33q34 region.
RESULTS: Genomic rearrangements ranged from 328 kb to 11.8 Mb, involving complete or partial duplication/triplication of COL4A1/2. Patients presented heterogeneous cerebrovascular manifestations, including ischemic and hemorrhagic events, motor impairment, and cognitive decline. Brain magnetic resonance imaging consistently showed extensive white matter hyperintensities, lacunes (particularly in the pons), microbleeds, and, in some cases, saccular aneurysms or arterial dolichoectasia. Only 2 probands had a positive family history of CSVD.
CONCLUSIONS: This large series confirms the pathogenicity of COL4A1/2 duplications and triplications in adult-onset CSVD. Phenotypic variability likely reflects differences in duplication/triplication size, gene content, and modifying factors. Our findings highlight a distinct cerebral-only phenotype linked to gene dosage-related overexpression and underscore the importance of screening for copy number variations in patients with otherwise unexplained cerebral microangiopathy, even in the absence of a family history.